News & Perspective

Nov 15, 2006

Nov 15, 2006

'Gene chip' test could speed H5N1 diagnosis

(CIDRAP News) – Scientists say they have developed an inexpensive "gene chip" test that can quickly identify a variety of influenza A viruses, including H5N1, and is less apt to be confused by viral mutations than other tests are.

Sep 26, 2006

Sep 26, 2006

WHO flu pandemic task force begins work

(CIDRAP News) – An international group of experts that will advise the World Health Organization (WHO) on avian and pandemic influenza issues met for the first time yesterday in Geneva, Switzerland.

Jul 05, 2006

Jul 05, 2006

HHS has enough H5N1 vaccine for 4 million people

(CIDRAP News) – In an update on pandemic influenza preparedness efforts, the federal government said last week it had stockpiled enough vaccine against H5N1 avian influenza virus to inoculate about 4 million people and enough antiviral medication to treat about 6.3 million.

May 24, 2006

May 24, 2006

Two generations of spread possible in Indonesia H5N1 cases

(CIDRAP News) – For the first time, evidence suggests that the H5N1 avian influenza virus may have passed from one person to another and on to a third, according to a World Health Organization (WHO) official.

Referring to the extended-family case cluster in Indonesia, the WHO's Maria Cheng told the Canadian Press (CP) yesterday, "This is the first time we have seen cases that have gone beyond one generation of human-to-human spread."

Mar 15, 2006

Mar 15, 2006

Leavitt vows action on flu vaccine technology

(CIDRAP News) – Health and Human Services (HHS) Secretary Mike Leavitt, reporting this week on preparations for a possible influenza pandemic, promised to act soon to boost US flu vaccine production capacity and promote cell-based vaccine technology.

Mar 07, 2006

Mar 07, 2006

HHS using Indonesian strain for second H5N1 flu vaccine

(CIDRAP News) – A second vaccine against human H5N1 influenza is being developed, US Health and Human Services (HHS) Secretary Mike Leavitt announced yesterday.

In a speech at an immunization conference, Leavitt announced that he has authorized the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) to start work on a second vaccine, according to an Associated Press (AP) report published yesterday.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»